Operational Components of Telemedicine Programs for Diabetic Retinopathy

Current Diabetes Reports

Volumn 16, Issue 12, 2016, Pages

  Horton, Mark B ^a   Silva, Paolo S ^b,c   Cavallerano, Jerry D ^b,c   Aiello, Lloyd Paul ^b,c  

^a INDIAN HEALTH SERVICE   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Telemedicine; Teleophthalmology

Indexed keywords

AUTOMATED IMAGE GRADING; COST EFFECTIVENESS ANALYSIS; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEALTH CARE QUALITY; HUMAN; IMAGE ANALYSIS; PRACTICE GUIDELINE; QUALITY CONTROL; RETINA EXAMINATION; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD; TELEMEDICINE; VALIDATION STUDY; COST BENEFIT ANALYSIS; PROCEDURES;

COST-BENEFIT ANALYSIS; DIABETIC RETINOPATHY; HUMANS; QUALITY ASSURANCE, HEALTH CARE; TELEMEDICINE;

EID: 84993993184     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-016-0814-7     Document Type: Review

References (61)

1. Horton MB, Silva PS, Cavallerano JD, Aiello LP. Clinical components of telemedicine programs for diabetic retinopathy. Curr Diab Rep. 2016. doi:10.1007/s11892-016-0813-8.
2. American Telemedicine Association, Telemedicine Glossary. (2016) Retrieved 17 October 2016 at http://thesource.americantelemed.org/resources/telemedicine-glossary/.
3. International Diabetes Federation. IDF Diabetes Atlas. 7th edn. Brussels, Belgium: International Diabetes Federation. 2015.
4. Tobin KW, Abramoff MD, Chaum E, Giancardo L, Govindasamy V, Karnowski TP, et al. Using a patient image archive to diagnose retinopathy. Conf Proc Annu Int Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol Soc Annu Conf. 2008;2008:5441–4.
5. Chaum E, Karnowski TP, Govindasamy VP, Abdelrahman M, Tobin KW. Automated diagnosis of retinopathy by content-based image retrieval. Retina. 2008;28(10):1463–77.
6. Cree MJ, Olson JA, McHardy KC, Sharp PF, Forrester JV. A fully automated comparative microaneurysm digital detection system. Eye (Lond). 1997;11(Pt 5):622–8.
7. Sim DA, Keane PA, Tufail A, Egan CA, Aiello LP, Silva PS. Automated retinal image analysis for diabetic retinopathy in telemedicine. Curr Diab Rep. 2015;15(3):577.
8. •Abramoff MD, Folk JC, Han DP, Walker JD, Williams DF, Russell SR, et al. Automated analysis of retinal images for detection of referable diabetic retinopathy. JAMA Ophthalmol. 2013;131(3):351–7. This is an important article reporting an automated reading system for DR-Tmed images demonstrating potential for point of care use for rapid triage and improved productivity and efficiency.
9. Fleming AD, Goatman KA, Philip S, Prescott GJ, Sharp PF, Olson JA. Automated grading for diabetic retinopathy: a large-scale audit using arbitration by clinical experts. Br J Ophthalmol. 2010;94(12):1606–10.
10. Soto-Pedre E, Navea A, Millan S, Hernaez-Ortega MC, Morales J, Desco MC, et al. Evaluation of automated image analysis software for the detection of diabetic retinopathy to reduce the ophthalmologists’ workload. Acta Ophthalmol. 2015;93(1):e52–56.
11. Usher D, Dumskyj M, Himaga M, Williamson TH, Nussey S, Boyce J. Automated detection of diabetic retinopathy in digital retinal images: a tool for diabetic retinopathy screening. Diabet Med. 2004;21(1):84–90.
12. Niemeijer M, van Ginneken B, Staal J, Suttorp-Schulten MS, Abramoff MD. Automatic detection of red lesions in digital color fundus photographs. IEEE Trans Med Imaging. 2005;24(5):584–92.
13. Quellec G, Lamard M, Cochener B, Decenciere E, Lay B, Chabouis A, et al. Multimedia data mining for automatic diabetic retinopathy screening. Conf Proc Annu Int Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol Soc Annu Conf. 2013;2013:7144–7.
14. •NHS diabetic eye screening (DES) programme. Retrieved at https://www.gov.uk/topic/population-screening-programmes/diabetic-eye. This article provides practice standards for DR-Tmed with an emphasis on quality assurance.
15. ••Li HK, Horton M, Bursell SE, Cavallerano J, Zimmer-Galler I, Tennant M, Abramoff M, Chaum E, Debuc DC, Leonard-Martin T, Association WAT, Working IGNIOSAT, Group M. Telehealth practice recommendations for diabetic retinopathy, Second Edition. Telemed J E Health. 2011. This article provides clinical, technical, and business practice recomendations for DR-Tmed.
16. Tozer K, Woodward MA, Newman-Casey PA. Telemedicine and diabetic retinopathy: review of published screening programs. J Endocrinol Diabetes. 2015;2(4).
17. ••Mansberger SL, Sheppler C, Barker G, Gardiner SK, Demirel S, Wooten K, et al. Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: a randomized clinical trial. JAMA Ophthalmol. 2015;133(5):518–25. This is an important randomized clinical trial showing the clinical effecivenes of primary care based non-mydriatic DR-Tmed as compared to conventional examination for detection and monitoring diabetic retionopathy.
18. Zimmer-Galler IE, Zeimer R. Telemedicine in diabetic retinopathy screening. Int Ophthalmol Clin. 2009;49(2):75–86.
19. Tang RA, Morales M, Ricur G, Schiffman JS. Telemedicine for eye care. J Telemed Telecare. 2005;11(8):391–6.
20. Wei JC, Valentino DJ, Bell DS, Baker RS. A Web-based telemedicine system for diabetic retinopathy screening using digital fundus photography. Telemed J E Health. 2006;12(1):50–7.
21. Silva PS, Cavallerano JD, Tolls D, Omar A, Thakore K, Patel B, et al. Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program. Diabetes Care. 2014;37(1):50–5.
22. Silva PS, Cavallerano JD, Tolson AM, Rodriguez J, Rodriguez S, Ajlan R, Tolls D, Patel B, Sehizadeh M, Thakore K, Sun JK, Aiello LP. Real-time ultrawide field image evaluation of retinopathy in a diabetes telemedicine program. Diabetes Care. 2015;38(9):1643–9.
23. Indian Health Service. IHS Clinical Reporting System. Retrieved 1 May 2016 at https://www.ihs.gov/crs/software/fy16/.
24. Garvican L, Scanlon PH. A pilot quality assurance scheme for diabetic retinopathy risk reduction programmes. Diabet Med. 2004;21(10):1066–74.
25. Garg S, Jani PD, Kshirsagar AV, King B, Chaum E. Telemedicine and retinal imaging for improving diabetic retinopathy evaluation. Arch Intern Med. 2012;172(21):1677–8.
26. Lemmetty R, Makela K. Mobile digital fundus screening of type 2 diabetes patients in the Finnish county of South-Ostrobothnia. J Telemed Telecare. 2009;15(2):68–72.
27. Chabouis A, Berdugo M, Meas T, Erginay A, Laloi-Michelin M, Jouis V, et al. Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. Diabetes Metab. 2009;35(3):228–32.
28. Taylor CR, Merin LM, Salunga AM, Hepworth JT, Crutcher TD, O’Day DM, et al. Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology: the Vine Hill study. Diabetes Care. 2007;30(3):574–8.
29. Wilson C, Horton M, Cavallerano J, Aiello LM. Addition of primary care-based retinal imaging technology to an existing eye care professional referral program increased the rate of surveillance and treatment of diabetic retinopathy. Diabetes Care. 2005;28(2):318–22.
30. Glasson NM, Crossland LJ, Larkins SL. An Innovative Australian outreach model of diabetic retinopathy screening in remote communities. J Diabetes Res. 2016;2016:1267215.
31. Olayiwola JN, Sobieraj DM, Kulowski K, St Hilaire D, Huang JJ. Improving diabetic retinopathy screening through a statewide telemedicine program at a large federally qualified health center. J Health Care Poor Underserved. 2011;22(3):804–16.
32. Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010. BMJ Open. 2014;4(2):e004015.
33. Invernizzi A, Bevilacqua MT, Cozzi M, Bianchi C, Pagani A, Cigada M, et al. Diabetic retinopathy screening: the first telemedical approach in an Italian hospital. Eur J Ophthalmol. 2016;26(4):369–74.
34. Kim J, Driver DD. Teleophthalmology for first Nations clients at risk of diabetic retinopathy: a mixed methods evaluation. JMIR Med Inf. 2015;3(1):e10.
35. Schiffman RM, Jacobsen G, Nussbaum JJ, Desai UR, Carey JD, Glasser D, et al. Comparison of a digital retinal imaging system and seven-field stereo color fundus photography to detect diabetic retinopathy in the primary care environment. Ophthalmic Surg Lasers Imaging Off J Int Soc Imaging Eye. 2005;36(1):46–56.
36. Aoki N, Dunn K, Johnson-Throop KA, Turley JP. Outcomes and methods in telemedicine evaluation. Telemed J E Health. 2003;9(4):393–401.
37. Vaziri K, Moshfeghi DM, Moshfeghi AA. Feasibility of telemedicine in detecting diabetic retinopathy and age-related macular degeneration. Semin Ophthalmol. 2015;30(2):81–95.
38. Rotvold GH, Knarvik U, Johansen MA, Fossen K. Telemedicine screening for diabetic retinopathy: staff and patient satisfaction. J Telemed Telecare. 2003;9(2):109–13.
39. Massin P, Aubert JP, Erginay A, Bourovitch JC, Benmehidi A, Audran G, et al. Screening for diabetic retinopathy: the first telemedical approach in a primary care setting in France. Diabetes Metab. 2004;30(5):451–7.
40. Massin P, Chabouis A, Erginay A, Viens-Bitker C, Lecleire-Collet A, Meas T, et al. OPHDIAT: a telemedical network screening system for diabetic retinopathy in the Ile-de-France. Diabetes Metab. 2008;34(3):227–34.
41. Taylor R. Practical community screening for diabetic retinopathy using the mobile retinal camera: report of a 12 centre study. British Diabetic Association Mobile Retinal Screening Group. Diabet Med. 1996;13(11):946–52.
42. Sreelatha OK, Ramesh SV. Teleophthalmology: improving patient outcomes? Clin Ophthalmol. 2016;10:285–95.
43. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276(15):1253–8.
44. Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–81.
45. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(1 Pt 2):164–9.
46. Whited JD, Datta SK, Aiello LM, Aiello LP, Cavallerano JD, Conlin PR, et al. A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E Health. 2005;11(6):641–51.
47. Rein DB, Wittenborn JS, Zhang X, Allaire BA, Song MS, Klein R, Saaddine JB, Group ftVC-ES. The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Serv Res. 2011.
48. Maberley D, Cruess AF, Barile G, Slakter J. Digital photographic screening for diabetic retinopathy in the James Bay Cree. Ophthalmic Epidemiol. 2002;9(3):169–78.
49. Rachapelle S, Legood R, Alavi Y, Lindfield R, Sharma T, Kuper H, et al. The cost-utility of telemedicine to screen for diabetic retinopathy in India. Ophthalmology. 2013;120(3):566–73.
50. Brady CJ, Villanti AC, Gupta OP, Graham MG, Sergott RC. Tele-ophthalmology screening for proliferative diabetic retinopathy in urban primary care offices: an economic analysis. Ophthalmic Surg Lasers Imaging Retin. 2014;45(6):556–61.
51. Li Z, Wu C, Olayiwola JN, Hilaire DS, Huang JJ. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy. Conn Med. 2012;76(2):85–90.
52. James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 2000;320(7250):1627–31.
53. Richardson DR, Fry RL, Krasnow M. Cost-savings analysis of telemedicine use for ophthalmic screening in a rural Appalachian health clinic. W V Med J. 2013;109(4):52–5.
54. Gomez-Ulla F, Alonso F, Aibar B, Gonzalez F. A comparative cost analysis of digital fundus imaging and direct fundus examination for assessment of diabetic retinopathy. Telemed J E Health. 2008;14(9):912–8.
55. Phan AD, Koczman JJ, Yung CW, Pernic AA, Doerr ED, Kaehr MM. Cost analysis of teleretinal screening for diabetic retinopathy in a county hospital population. Diabetes Care. 2014;37(12):e252–253.
56. Bjorvig S, Johansen MA, Fossen K. An economic analysis of screening for diabetic retinopathy. J Telemed Telecare. 2002;8(1):32–5.
57. Scotland GS, McNamee P, Philip S, Fleming AD, Goatman KA, Prescott GJ, et al. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland. Br J Ophthalmol. 2007;91(11):1518–23.
58. Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med. 2010;27(3):249–56.
59. Au A, Gupta O. The economics of telemedicine for vitreoretinal diseases. Curr Opin Ophthalmol. 2011;22(3):194–8.
60. Silva PS, Horton MB, Clary D, Lewis DG, Sun JK, Cavallerano JD, Aiello LP. Identification of diabetic retinopathy and ungradable image rate with ultrawide field imaging in a national teleophthalmology program. Ophthalmology. 2016.
61. •Chasan JE, Delaune B, Maa AY, Lynch MG. Effect of a teleretinal screening program on eye care use and resources. JAMA Ophthalmol. 2014;132(9):1045–51. This article reports the cost effeciveness of DR-Tmed from the vantage of indirect resource allocation resulting from diabetic and non-diabetic referrals from the program.